首页 | 本学科首页   官方微博 | 高级检索  
     

复方盐酸表柔比星聚乳酸-羟基乙酸共聚物纳米粒的制备及含量测定
引用本文:Ji JS,Fu HX,Song JJ,Li H,Zhu YL. 复方盐酸表柔比星聚乳酸-羟基乙酸共聚物纳米粒的制备及含量测定[J]. 中华医学杂志, 2011, 91(47): 3371-3373. DOI: 10.3760/cma.j.issn.0376-2491.2011.47.015
作者姓名:Ji JS  Fu HX  Song JJ  Li H  Zhu YL
作者单位:1. 210096 南京,东南大学临床医学博士后流动站;浙江省丽水市中心医院放射科
2. 温州医学院药学院
3. 丽水市中心医院放射科
基金项目:卫生部科研基金,江苏省博士后科研基金
摘    要:目的 制备复方盐酸表柔比星聚乳酸-羟基乙酸共聚物( PLGA)纳米粒,并对其含量进行测定.方法 采用乳化-溶剂挥发法制备复方盐酸表柔比星纳米粒,添加适量乳糖后采用冷冻干燥法制备得到复方盐酸表柔比星纳米粒冻干粉,通过反相高效液相法测定盐酸表柔比星和钆喷酸双葡甲胺的含量和释放度.结果 制备得到复方盐酸表柔比星PLGA纳米粒,初步建立了可同时测定两种药物成分的高效液相含量测定方法,复方制剂中盐酸表柔比星和钆喷酸双葡甲胺的含量分别为100.6%±1.6%、99.1%±1.9%,且两种成分均能在9d内释放完全.结论 本方法制备复方盐酸表柔比星PLGA纳米粒简便可行,所拟定的含量测定方法可行.

关 键 词:表柔比星  葡甲胺  复方

Preparation and quality control of compound epirubicin hydrochloride-loaded polymeric nanoparticles of L-lactic-co-glycolic acid
Ji Jian-song,Fu Hong-xing,Song Jing-jing,Li Hui,Zhu Yan-lin. Preparation and quality control of compound epirubicin hydrochloride-loaded polymeric nanoparticles of L-lactic-co-glycolic acid[J]. Zhonghua yi xue za zhi, 2011, 91(47): 3371-3373. DOI: 10.3760/cma.j.issn.0376-2491.2011.47.015
Authors:Ji Jian-song  Fu Hong-xing  Song Jing-jing  Li Hui  Zhu Yan-lin
Affiliation:The Medical School of Southeast University, Postdoctoral Mobile Research Station, Nanjing 210096, China. jjstcty@sina.com
Abstract:Objective To prepare compound epirubicin hydrochloride-loaded polymeric nanoparticles of L-lactic-co-glycolic acid and establish their quality control.Methods The emulsion-solvent evaporation method was employed to prepare and freeze-dry the compound epirubicin hydrochloride-loaded polymeric nanoparticles of L-lactic-co-glycolic acid after the addition of lactose.The contents and cumulative release of epirubicin hydrochloride and dimeglumine gadopentetate were detected simultaneously by RPHPLC (reverse phase-high performance liquid chromatography).Results The above nanoparticles were prepared and the quality standards for simultaneously determining the contents of epirubicin hydrochloride and dimeglumine gadopentetate established primarily.The contents of epirubicin hydrochloride and dimeglumine gadopentetate in compound preparation were 100.6% ± 1.6% and 99.1% ± 1.9%respectively.And two compositions could be completely released within 9 days.Conclusion The preparation method of nanoparticles is simple and their quality control feasible.
Keywords:Epirubicin  Meglumine  Compounds
本文献已被 万方数据 PubMed 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号